Actively Recruiting

Phase 2
Age: 18Years +
All Genders
NCT05709782

Phase II Cohort of Spinal Stereotactic Radiotherapy in Patients Using a MR LINAC

Led by M.D. Anderson Cancer Center · Updated on 2026-01-14

40

Participants Needed

1

Research Sites

142 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

To learn whether giving spinal stereotactic radiosurgery (SRSS) that uses a more advanced imaging scan method called Magnetic Resonance imaging with a Linear Accelerator (MR-LINAC) during treatment will lead to improved responses to treatment and better quality of life. SRSS is radiation therapy given to the area around your spine.

CONDITIONS

Official Title

Phase II Cohort of Spinal Stereotactic Radiotherapy in Patients Using a MR LINAC

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Radiographically confirmed spinal disease within 4 weeks of registration
  • Eligible for spine stereotactic radiosurgery or stereotactic body radiation therapy as determined by treating physician or spine conference
  • Maximum of 3 contiguous vertebral levels involved with spine metastasis to be treated
  • Documented diagnosis of cancer
  • Motor strength of at least 4 out of 5 in the affected extremity
  • Karnofsky Performance Score of 40 or higher or ECOG score of 3 or lower
Not Eligible

You will not qualify if you...

  • Patients with highly radiosensitive cancers likely to respond to conventional radiation alone (such as lymphoma or multiple myeloma)
  • Unable to undergo MRI of the spine with contrast
  • Pregnant patients

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

M D Anderson Cancer Center

Houston, Texas, United States, 77030

Actively Recruiting

Loading map...

Research Team

D

Debra N. Yeboa, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here